Our News on Newswise

Single-cell sequencing and bioinformatic tools applications discussed in Research Review

Nowadays, single-cell RNA sequencing technologies and related bioinformatics tools are emerging as essential devices for dissecting tumors at single-cell resolution and understanding carcinogenesis and drug response mechanisms, representing a...
30-Nov-2021 1:35 PM EST Add to Favorites

Newswise: 619d0195e5227_shro.JPG

Tumor Blood Vessel Growth May Be Target to Treat Glioblastoma and Other Cancers

A novel protein regulator of tumor angiogenesis, TMEM230, was recently characterized by researchers to have a role in tumor development and vascularization, with potential as a target for anti-tumor therapy in difficult-to-treat cancers such as...
23-Nov-2021 10:10 AM EST Add to Favorites

Newswise: 618554c381467_gio.JPG

SHRO’s Giordano Meets with Appropriations Committee Chair on Capitol Hill

Professor Antonio Giordano, M.D., Ph.D., Neapolitan Oncologist, Director of the Sbarro Institute for Cancer Research at Temple University and founder of the Sbarro Health Research Organization (SHRO), met today with Congresswoman Rosa DeLauro...
5-Nov-2021 2:55 PM EDT Add to Favorites

Newswise: 6180189b52a16_shro.PNG

Research Supports More Effective Choices Than Ever for Drug-Free Pain Relief During Labor and Delivery

Researchers coordinated by Professor Antonio Giordano, M.D., Ph.D., Founder and Director of the Sbarro Health Research Organization (SHRO) have highlighted the effectiveness of non-pharmacological analgesic techniques during childbirth in a review...
4-Nov-2021 10:30 AM EDT Add to Favorites

Newswise: giordano-giorgetti.png

National Italian American Foundation Awards Fauci Scholarships at Annual Gala

NIAF Board Member and SHRO Director Antonio Giordano leads scholarship committee.
28-Oct-2021 9:00 AM EDT Add to Favorites

Elucidation of Novel mechanisms regulating the tumor suppressor RBL1/p107 levels in mesothelioma and lung cancer cells


8-Oct-2021 3:40 PM EDT Add to Favorites

Fungal and Bacterial Biodeterioration of Outdoor Canvas Paintings: The Case of the Cloisters of Quito, Ecuador

The journal Critical Review In Eukaryotic Gene Expression has just published an interesting article entitled: “Fungal And Bacterial Biodeterioration Of Outdoor Canvas Paintings: The Case Of The Cloisters Of Quito, Ecuador.”
25-Aug-2021 5:30 PM EDT Add to Favorites

GYNOCARE COST Creates International Research Collab on Rare Cancers Affecting Millions of Women Annually

Sbarro Health Research Organization (SHRO) Founder and Director, Antonio Giordano, M.D., Ph.D., of Temple University and the University of Siena, Italy, is part of the GYNOCARE COST Action (CA18117) chaired by Prof Jean Calleja Agius of the...
20-Aug-2021 2:45 PM EDT Add to Favorites


See All News

Our Experts on Newswise

Precision Medicine and the Anti-Cancer Properties of Foods like Green Tea, SHRO Founder Comments

2-Mar-2021 8:15 AM EST

"We've got to get our act together" on public health measures to combat COVID, says Fauci

3-Nov-2020 2:35 PM EST

‘Genetic Shield’ May Explain Lower COVID Mortality in Southern Italy Compared to North

4-Jun-2020 9:55 AM EDT

Coronavirus: concern and precaution ok, but panic and hysteria unjustified, says expert

COVID-19 is similar in symptoms to the seasonal flu, but to recognize it there is a different procedure and we have to act accordingly
6-Mar-2020 8:20 AM EST

Cancer DNA Sequencing Has Potential, but Not a Magic Bullet, Says Expert

16-Jan-2018 11:05 AM EST

Newswise: Slide1.jpg

Thorough Genotyping and Repurposed Drugs Key to Treating Small-Cell Lung Cancer, says Cancer Expert

Cancer expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, describes the recent progress and future possibilities of treating SCLC.
13-Apr-2017 7:05 AM EDT

Newswise: giordanoheadshot.png

Every Diagnosis of Cancer Should Come with One of These, Says Cancer Expert

“Every cancer diagnosis should come with a referral to genetic counseling,” says cancer expert Dr. Antonio Giordano, President of the Sbarro Health Research Organization at Temple University.
8-Feb-2017 10:30 AM EST

See All Experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.

About

Sbarro Health Research Organization conducts research in cancer, diabetes, and cardiovascular disease. Based in Philadelphia, Pennsylvania on the campus of Temple University, our programs train young scientists from around the globe.

Experts

Contacts

Barbara Colombo

barbaracolombo@ble-group.com

Antonio Giordano
President

president@shro.org

+1215-204-9520

Twitter

close
0.31865